Found 558 results
Chewapreecha, C. et al. Comprehensive Identification of Single Nucleotide Polymorphisms Associated with Beta-lactam Resistance within Pneumococcal Mosaic Genes. PLoS Genet 10, e1004547 (2014).
Chewapreecha, C. et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet 46, 305-9 (2014).
Zongo, I. et al. Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine. PLoS One 9, e103200 (2014).
Seale, A. C. et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. The Lancet Infectious Diseases 14, 731-741 (2014).
Croucher, N. J. et al. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape. Genome Biol Evol 6, 1589-602 (2014).
Tanomsing, N. et al. Genetic Variability of Plasmodium malariae dihydropteroate synthase (dhps) in Four Asian Countries. PLoS ONE 9, e93942 (2014).
Tyrosvoutis, M. Ellen G. et al. Gestational diabetes mellitus prevalence in Maela refugee camp on the Thai–Myanmar Border: a clinical report. Global Health Action (2014). at <>
Price, R. N. et al. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet Infectious Diseases (2014). at <>
J. Baird, K. , Satyagraha, A. & Bancone, G. . Glucose-6-Phosphate Dehydrogenase Deficiency and Primaquine Hemolytic Toxicity. Encyclopedia of Malaria (Springer-Verlag Berlin Heidelberg, 2014). doi:10.1007/SpringerReference_372406
Lee, W. C. et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. Blood 123, e100-e109 (2014).
Lee, Y. Q. et al. A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-dichlorobenzamil on the digestive vacuole of Plasmodium falciparum. Antimicrob Agents Chemother 58, 550-8 (2014).
Imwong, M. et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol 52, 3303-9 (2014).
Malmquist, N. A. et al. Histone methyltransferase inhibitors: orally bioavailable, fast acting molecules with activity against different human malaria species. Antimicrob Agents Chemother 59, 950:959 (2014).
Takala-Harrison, S. et al. Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia. J Infect Dis (2014). doi:10.1093/infdis/jiu491
Tan, J. J. L. et al. An Integrated Lab-on-Chip for Rapid Identification and Simultaneous Differentiation of Tropical Pathogens. PLoS Negl Trop Dis 8, e3043 (2014).
Vicentin, E. C. et al. Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast. Infect Immun 82, 1296-1307 (2014).
Kuhen, K. L. et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment and prevention of disease transmission. Antimicrob Agents Chemother (2014). doi:10.1128/AAC.02727-13
Pratt, B. et al. Linking international clinical research with stateless populations to justice in global health. BMC Med Ethics 15, 49 (2014).
Chaikitgosiyakul, S. et al. A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection. Malar J 13, 4 (2014).
Lwin, K. Maung et al. Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border. BMC Medical Ethics 15, 12 (2014).
Malleret, B. et al. Plasmodium vivax: restricted tropism and rapid remodelling of CD71 positive reticulocytes. Blood (2014). doi:10.1182/blood-2014-08-596015
Preston, M. D. et al. PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation. J Infect Dis 209, 1808-15 (2014).
Venkatesan, M. et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg 91, 833-43 (2014).
Tarning, J. et al. Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria. Antimicrob Agents Chemother 58, 2052-2058 (2014).
Tarning, J. et al. Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand. CPT: pharmacomet. syst. pharmacol. 3, e132 (2014).




Shoklo Malaria Research Unit
68/30 Bantung Road, PO Box 46
Mae Sot, Tak 63110 Thailand

Tel: +66 (0) 55 532 026
       +66 (0) 55 532 028
Fax: +66 (0) 55 532 027
Email SMRU

Zircon - This is a contributing Drupal Theme
Design by WeebPal.